Primary enteropathy-associated T-cell lymphoma type 2: An emerging entity?

8Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Intestinal T-cell lymphoma is a rare hemato­logical malignancy that can present as primary intesti­nal lymphoma or as a manifestation of systemic disease. Primary involvement accounts for approximately 0.1% to 0.5% of all colorectal neoplasms. It is an aggressive disease with a poor prognosis and low survival rate. Inflammatory bowel disease, celiac disease, im­munosuppression, and infectious etiologies, such as Epstein-Barr and human T-lymphotropic viruses, have been reported as risk factors, but no direct causal link has been established. Herein, we examine the case of a Hispanic man 69 years of age diagnosed with positive CD3, CD7, CD8, CD43, and Bcl-2 diffuse primary colorectal T-cell lymphoma. The patient did not exhibit a concomitant autoim­mune or genetic disease. Because of the patient's history of polyps, surveillance colonoscopy was performed and the diagnosis was confirmed.

Cite

CITATION STYLE

APA

Grigg-Gutierrez, N. M., Estremera-Marcial, R., Cáceres, W. W., & Toro, D. H. (2015). Primary enteropathy-associated T-cell lymphoma type 2: An emerging entity? Cancer Control, 22(2), 242–247. https://doi.org/10.1177/107327481502200218

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free